1.37  0.03 (2.24%)		01-30 16:00
Open: 1.35 High: 1.47 Volume: 285,674		Pre. Close: 1.34 Low: 1.31 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	1.94	1-year :	2.87
Resists	First :	1.66	Second :	2.46
Pivot price	0.92
Supports	First :	0.38	Second :	0.32
MAs	MA(5) :	1.52	MA(20) :	0.85
	MA(100) :	4.12	MA(250) :	74.77
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	49.8	D(3) :	54.3
RSI	RSI(14): 56.2
52-week	High :	721.75	Low :	0.38

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NIVF ] has closed below upper band by 29.3%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1.47 - 1.48	1.48 - 1.48
Low:	1.29 - 1.3	1.3 - 1.31
Close:	1.33 - 1.34	1.34 - 1.35

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Tue, 27 Jan 2026
NewGen to Execute Up to US$2 Million Share Repurchase Program Through Benchmark - marketscreener.com

Tue, 27 Jan 2026
NewGenIVF to execute $2 million share repurchase program - Investing.com

Wed, 21 Jan 2026
NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts - FinancialContent

Sat, 06 Dec 2025
NewGenIvf Group (NIVF) Price Target Increased by 400.00% to 76.50 - Nasdaq

Tue, 02 Dec 2025
NewGenIvf Group Sees Surprising Movement - StocksToTrade

Mon, 01 Dec 2025
NewGenIvf Group Announces Reverse Stock Split Effective December 1, 2025 - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	0 (M)
Shares Float	1 (M)
Held by Insiders	430270 (%)
Held by Institutions	0.2 (%)
Shares Short	11 (K)
Shares Short P.Month	0 (K)

EPS	1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	381.1 %
Operating Margin	-196 %
Return on Assets (ttm)	-23.1 %
Return on Equity (ttm)	160.5 %
Qtrly Rev. Growth	-12.9 %
Gross Profit (p.s.)	0.3
Sales Per Share	0.98
EBITDA (p.s.)	-0.85
Qtrly Earnings Growth	398.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	1.34
PEG Ratio	0
Price to Book value	0
Price to Sales	1.35
Price to Cash Flow	-0.01

Dividend	0
Forward Dividend	13900
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.